Drug Profile
Kangdaprevir sodium - Sunshine Lake Pharma
Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator Sunshine Lake Pharma
- Developer First Hospital of Jilin University; Sunshine Lake Pharma
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Chronic hepatitis
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for phase-I development in Chronic-hepatitis(In volunteers) in China (PO, Tablet)
- 29 May 2018 Sunshine Lake Pharma completes phase I trials in Chronic hepatitis (In volunteers) in China (PO) (NCT03811678) (ChiCTR1800014487)
- 09 Jan 2018 Phase-I clinical trials in Chronic hepatitis (In volunteers) in China (ChiCTR1800014487)